MediFind
Condition

Calciphylaxis

Latest Research

Latest Advance
Study
  • Condition: Tumoral Calcinosis (TC) in Uremic Patients with Secondary Hyperparathyroidism (SHPT)
  • Journal: BMC surgery
  • Treatment Used: Parathyroidectomy (PTX)
  • Number of Patients: 9
  • Published —
This study investigated the relationship between parathyroidectomy (PTX) and shrinkage of tumoral calcinosis (TC), a rare disease derived from uremic secondary hyperparathyroidism (SHPT).
Latest Advance
Study
  • Condition: Single Infected Calciphylaxis Lesion
  • Journal: Wounds : a compendium of clinical research and practice
  • Treatment Used: Intralesional Injection of Sodium Thiosulfate (STS) at High Concentration
  • Number of Patients: 1
  • Published —
This case report discusses a 51-year-old man with end-stage renal disease (ESRD) diagnosed with an infected calciphylaxis lesion and treated with intralesional injection of sodium thiosulfate (STS).
Latest Advance
Study
  • Condition: Calcific Uremic Arteriolopathy (CUA)
  • Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia
  • Treatment Used: Sodium Thiosulfate (STS)
  • Number of Patients: 1
  • Published —
This study evaluated the effectiveness of sodium thiosulphate in a patient with calcific uremic arteriolopathy (when calcium accumulates in small blood vessels of the fat and skin tissues; CUA).
Latest Advance
Study
  • Condition: Acenocoumarol-Associated Calciphylaxis
  • Journal: The Australasian journal of dermatology
  • Treatment Used: Drug Withdrawal
  • Number of Patients: 5
  • Published —
This case report describes female patients with acenocoumarol-associated calciphylaxis that were treated using interruption of acenocoumarol for anticoagulant therapy.
Latest Advance
Study
  • Condition: Calciphylaxis in patients with chronic kidney disease
  • Journal: The Australasian journal of dermatology
  • Treatment Used: Cinacalcet
  • Number of Patients: 0
  • Published —
The study researched the safety and effectiveness of cinacalcet for treating calciphylaxis in patients with chronic kidney disease.
Latest Advance
Study
  • Condition: Secondary hyperparathyroidism (SHPT)
  • Journal: BMC nephrology
  • Treatment Used: Cessation of cinacalcet
  • Number of Patients: 62
  • Published —
This study evaluated the longitudinal changes and clinical outcomes in patients with secondary hyperparathyroidism (SHPT) who are under dialysis management and who have suspended cinacalcet.
Latest Advance
Study
  • Condition: Secondary hyperparathyroidism (SHPT)
  • Journal: International urology and nephrology
  • Treatment Used: Calcimimetic medications (Cinacalet)
  • Number of Patients: 0
  • Published —
This study evaluated the effects of targeted therapies such as Cinacalet which act on negatively feedback on the parathyroid gland for patients with secondary hyperparathyroidism (SHPT).